Cassava Sciences (NASDAQ:SAVA) has tapped Freda Nassif as chief commercial officer, effective Nov. 18, 2024. Ms. Nassif is an ...

AUSTIN, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology ...

NAROCAS 1 is a high-yielding cassava variety developed by the National Agricultural Research Organisation (NARO) and released ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

CMO of Cassava Technologies, Ifeoma Jibunoh, shares her insights on storytelling, customer-centricity, and the role of AI in ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

STAT+ subscribers can sign up here to get it delivered to their inbox. As we count down toward the December readout of ...

Bearish flow noted in Cassava Sciences (SAVA) with 3,180 puts trading, or 1.8x expected. Most active are 11/22 weekly 13 puts and 11/22 weekly 25 puts, with total volume in those strikes near 1,000 ...

A super easy and delicious bread can be made with just one ingredient: cassava flour! It's healthy and gluten-free. You ...

What is cassava?  Cassava, also known as manioc or yuca (yep, cassava and yuca are the same things), is a starchy root ...

Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024 $149.0 Million in Cash and Cash ...